keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
DAY ONE
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
DAY ONE
search
Streams
Formats
8:30am - 9:00am
Conference Registration
Showing 2 of 2 Streams
Medical Device Regulatory Project Management Workshop
Biological Evaluation Execution & Authorship Training Workshop
9:00am - 9:05am
Chairperson’s Opening Remarks
- David Rutledge - President & CEO, Global Strategic Solutions
- Lindsey Zocolo - Global Program Manager, Medical Device Testing, TÜV SÜD
9:05am - 10:35am
Development Stages
- Regulatory considerations in early development
- Access publicly available databases early on
- “Can you sell me this pen?” Three easy steps to develop an initial regulatory, quality, and clinical strategy and then sell it to senior management.
- Establishing and initiating the project
- Mapping out timelines, responsibilities, and management
- Records management and documentation
- Identify ways to incorporate quality planning into a project
- Common myths, best practices, and tools – Lessons learned
10:35am - 11:05am
Networking Break
11:05am - 11:50am
Regulations and Standards in Project Management for Medical Devices
- Which regulations and standards apply to your device?
- Establishing and monitoring standards in medical deviceproject management
- Incorporating regulatory requirements and considerationsthroughout the medical device lifecycle (clinical evaluation,safety, and risk management)
- Additional regulatory considerations for project management(quality system requirements, design control, vendor control)
- Common myths, best practices, and tools – Lessons learned
11:50am - 12:35pm
Incorporation of Clinical Evaluation in Project Management
- Systematic literature reviews, appraising and analyzing literature
- Clinical investigations, registries, hospital databases, and surveys
- Post-market activities, complaint handling, vigilance, and CAPA
- Access publicly available databases
- Common myths, best practices, and tools – Lessons learned
12:35pm - 1:05pm
Networking Lunch
1:05pm - 1:35pm
Chairperson’s Afternoon Remarks
- David Rutledge - President & CEO, Global Strategic Solutions
- Lindsey Zocolo - Global Program Manager, Medical Device Testing, TÜV SÜD
1:35pm - 2:20pm
Establishing Risk Management in Project Management
- Practicalities of risk management
- Benefit-risk analysis – the unsolvable equation
- Common myths, best practices, and tools – Lessons learned
3:10pm - 3:40pm
Networking Break
3:40pm - 4:30pm
Managing Medical Device Project Cycles
- Metrics used for project management
- Metrics used for notified body performance
- Adapting to change – significant changes will occur
- Understanding full lifecycle expectations
- Discuss how to optimize team performance, communication, and interaction
- Common myths, best practices, and tools – Lessons learned
4:30pm - 5:05pm
End of Course Feedback Session
Delegates will get the opportunity to finish the course by asking any remaining questions and queries regarding the course content.
9:00am - 9:05am
Chairperson’s Opening Remarks
- Beau Rollins - Director, Quality Services, ConvaTec
9:05am - 10:35am
Foundations to Biological Evaluations
- The beginnings of the BE
- Intent of a BE
- Definitions and foundations
- Standard intent vs regulator interpretation
10:35am - 11:05am
Networking Break
11:05am - 11:50am
Process in Creating a Biological Evaluation Plan
- Utilizing Design inputs
- How to properly define intended use and devicecategorization
- Literature search
- How to reference competitive devices
- Clinical evaluation data integration
- Group divisions and BEP creation exercise
- Marina Daineko - Biocompatibility Consultant, Intrinsic Medical Group, LLC
11:50am - 12:35pm
Test Design for BEP
- E&L test requirements and set up
- Correct Dose Base Threshold (DBT) for device
- Calculation of Analytical Evaluation Threshold (AET)
- Method Uncertainty Factor (UF), sensitivity, solvent selection
- Applying to intended use and materials
- Traditional endpoint tests and critical factors
- In-vitro vs In-vivo
- Extraction time, temp, and ratios
- Determining gaps from E&L, literature, etc to determine appropriate endpoint test
- Group division and BEP completion
- Matthew Jorgensen - Toxicologist, Global Biocompatibility, Teleflex
12:35pm - 1:35pm
Networking Lunch
1:35pm - 1:40pm
Chairperson’s Afternoon Remarks
- Beau Rollins - Director, Quality Services, ConvaTec
1:40pm - 2:25pm
Understanding and Interpreting Test Results
- E&L test reports and applying AET for compound analysis
- Acceptance criteria for traditional endpoint tests
- Common deviations
- What to do if you fail
- Matthew Jorgensen - Toxicologist, Global Biocompatibility, Teleflex
2:25pm - 3:10pm
Transitioning into a Biological Evaluation Report
- Addition of all test data and results determination
- Gap assessment to data, deviations, historical testing
- Developing a final conclusion
- Group division and BER completion
- Marina Daineko - Biocompatibility Consultant, Intrinsic Medical Group, LLC
3:10pm - 3:40pm
Networking Break
3:40pm - 4:25pm
Toxicology Section
- Evaluating compounds
- NOAEL/LOAEL
- Cramer categorization
- Unknown determination
- MOS calculation per ISO 10993-17
- Group division and Tox assessment
- Matthew Jorgensen - Toxicologist, Global Biocompatibility, Teleflex
4:25pm - 4:55pm
Life of the Biological Evaluation
- Living document
- Requirements around accuracy
- CCR Impacts and device evolution
5:05pm - 5:10pm
End of Workshops
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats
Choose Day